Martine van Vugt
Director/Board Member at SCANDION ONCOLOGY A/S
Profile
Martine J.
van Vugt is currently an Independent Director at Scandion Oncology A and a Director at Hollandbio.
She is also the Chief Strategy Officer & Executive Vice President at Genmab A.
Additionally, she serves as a Member-Supervisory Board at Flindr Therapeutics BV.
Previously, she was an Independent Member-Supervisory Board at TME Pharma NV.
Dr. van Vugt holds a doctorate degree from the University of Utrecht and a graduate degree from Wageningen University.
Martine van Vugt active positions
| Companies | Position | Start |
|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 2023-03-28 |
| SCANDION ONCOLOGY A/S | Director/Board Member | 2022-03-31 |
Immagene BV
 Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Director/Board Member | - |
| Hollandbio | Director/Board Member | - |
Former positions of Martine van Vugt
| Companies | Position | End |
|---|---|---|
| TME PHARMA N.V. | Director/Board Member | 2023-06-28 |
Training of Martine van Vugt
| University of Utrecht | Doctorate Degree |
| Wageningen University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GENMAB A/S | Health Technology |
| TME PHARMA N.V. | Health Technology |
| SCANDION ONCOLOGY A/S | Health Technology |
| Private companies | 2 |
|---|---|
| Hollandbio | |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Martine van Vugt
